Increasing medication adherence to improve patient´s safety in cardiological rehabilitatio
Not yet recruiting
- Conditions
- medication adherenceE10-E14I10-I15Diabetes mellitusHypertensive diseases
- Registration Number
- DRKS00011134
- Lead Sponsor
- Medizinische Fakultät, Medizinische Psychologie und Medizinische Soziologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 886
Inclusion Criteria
presence of cardiovascular diseases; minimum age: 18 years; good physical, mental and psychological general condition; written declaration of consent
Exclusion Criteria
insufficient knowledge of german; acute psychiatric or neurological diseases
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary target is medication adherence, which is determined by means of standardized and modified questionnaires (self-constructed items in close relation to MMAS-8 [Moriscy Medication Adherence Scale]; MARS-D [Medication Adherence Report Scale;<br>Version]) at a measurement time (cross-sectional design). In addition to the operationalization of medication adherence, the correlations of the target criteria as well as the self-made and modified questionnaires are examined psychometrically.
- Secondary Outcome Measures
Name Time Method Secondary target variables are patient satisfaction with the information obtained on medication (SIMS-D (Satisfaction with Information about Medicines<br>Scale, German version) as well as patient participation (PEF-FB-9, revised 9-item version).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie medication non-adherence in cardiological rehabilitation for diabetes mellitus patients?
How does the PaSiMed observational study compare adherence interventions with standard-of-care in hypertension management?
Are there specific biomarkers that identify high-risk patients for poor medication adherence in DRKS00011134?
What adverse events are associated with adherence improvement strategies in cardiological rehabilitation?
What combination approaches enhance medication adherence in patients with E10-E14 and I10-I15 comorbidities?